101 related articles for article (PubMed ID: 12919021)
1. Stereoselective total synthesis of racemic BCX-1812 (RWJ-270201) for the development of neuraminidase inhibitors as anti-influenza agents.
Mineno T; Miller MJ
J Org Chem; 2003 Aug; 68(17):6591-6. PubMed ID: 12919021
[TBL] [Abstract][Full Text] [Related]
2. Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity.
Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin TH; Hutchison TL; Babu YS; Bantia S; Elliott AJ; Montgomery JA
J Med Chem; 2001 Dec; 44(25):4379-92. PubMed ID: 11728184
[TBL] [Abstract][Full Text] [Related]
3. BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.
Babu YS; Chand P; Bantia S; Kotian P; Dehghani A; El-Kattan Y; Lin TH; Hutchison TL; Elliott AJ; Parker CD; Ananth SL; Horn LL; Laver GW; Montgomery JA
J Med Chem; 2000 Sep; 43(19):3482-6. PubMed ID: 11000002
[No Abstract] [Full Text] [Related]
4. RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza.
Young D; Fowler C; Bush K
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1905-13. PubMed ID: 11779391
[TBL] [Abstract][Full Text] [Related]
5. Population analysis of the pharmacokinetics and pharmacodynamics of RWJ-270201 (BCX-1812) in treating experimental influenza A and B virus in healthy volunteers.
Iyer GR; Liao S; Massarella J
AAPS PharmSci; 2002; 4(4):E22. PubMed ID: 12645994
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
Bantia S; Parker CD; Ananth SL; Horn LL; Andries K; Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin T; Hutchison TL; Montgomery JA; Kellog DL; Babu YS
Antimicrob Agents Chemother; 2001 Apr; 45(4):1162-7. PubMed ID: 11257030
[TBL] [Abstract][Full Text] [Related]
7. RWJ-270201 BioCryst Pharmaceuticals/Johnson & Johnson.
Barnard DL
Curr Opin Investig Drugs; 2000 Dec; 1(4):421-4. PubMed ID: 11249693
[TBL] [Abstract][Full Text] [Related]
8. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
Mancuso CE; Gabay MP; Steinke LM; Vanosdol SJ
Ann Pharmacother; 2010; 44(7-8):1240-9. PubMed ID: 20516360
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of influenza neuraminidase inhibitors.
Abdel-Magid AF; Maryanoff CA; Mehrman SJ
Curr Opin Drug Discov Devel; 2001 Nov; 4(6):776-91. PubMed ID: 11899618
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors.
Liu Y; Zhang L; Gong J; Fang H; Liu A; Du G; Xu W
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):506-13. PubMed ID: 21143042
[TBL] [Abstract][Full Text] [Related]
11. The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase.
Bromba CM; Mason JW; Brant MG; Chan T; Lunke MD; Petric M; Boulanger MJ; Wulff JE
Bioorg Med Chem Lett; 2011 Dec; 21(23):7137-41. PubMed ID: 22001088
[TBL] [Abstract][Full Text] [Related]
12. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
Magano J
Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
[No Abstract] [Full Text] [Related]
13. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
Hurt AC; Selleck P; Komadina N; Shaw R; Brown L; Barr IG
Antiviral Res; 2007 Mar; 73(3):228-31. PubMed ID: 17112602
[TBL] [Abstract][Full Text] [Related]
15. The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.
Birnkrant D; Cox E
N Engl J Med; 2009 Dec; 361(23):2204-7. PubMed ID: 19884645
[No Abstract] [Full Text] [Related]
16. [Neuraminidase inhibitor].
Kaji M
Nihon Rinsho; 2000 Nov; 58(11):2293-8. PubMed ID: 11225320
[TBL] [Abstract][Full Text] [Related]
17. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
Stanley M; Martin SR; Birge M; Carbain B; Streicher H
Org Biomol Chem; 2011 Aug; 9(16):5625-9. PubMed ID: 21720632
[TBL] [Abstract][Full Text] [Related]
18. High-yielding synthesis of the anti-influenza neuraminidase inhibitor (-)-oseltamivir by two "one-pot" sequences.
Ishikawa H; Suzuki T; Orita H; Uchimaru T; Hayashi Y
Chemistry; 2010 Nov; 16(42):12616-26. PubMed ID: 20859964
[TBL] [Abstract][Full Text] [Related]
19. A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor oseltamivir from 1,3-butadiene and acrylic acid.
Yeung YY; Hong S; Corey EJ
J Am Chem Soc; 2006 May; 128(19):6310-1. PubMed ID: 16683783
[TBL] [Abstract][Full Text] [Related]
20. Neuraminidase inhibitors and relief of influenza symptoms.
Lemon M; Meade F
S D J Med; 2000 Mar; 53(3):99-100. PubMed ID: 10745653
[No Abstract] [Full Text] [Related]
[Next] [New Search]
